NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / All you need to know about WHO's global COVAX initiative
    All you need to know about WHO's global COVAX initiative
    World

    All you need to know about WHO's global COVAX initiative

    Written by Siddhant Pandey
    August 26, 2020 | 01:13 am 3 min read
    All you need to know about WHO's global COVAX initiative

    With little hope that the coronavirus pandemic is going to slow down any time soon, all eyes are on the development of a vaccine against SARS-CoV-2. The World Health Organization is leading an initiative, COVAX, to ensure that when the vaccine is ready, those who are at a greater risk of infection are the first to receive it. Here's all about it.

    What is COVAX?

    The COVAX initiative is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), the Gavi vaccine alliance, and the WHO. It is aimed at ensuring equitable access to COVID-19 vaccines across the world, once the vaccines are licensed and approved. The initiative is part of a larger plan, called the Access to COVID-19 Tools (ACT) Accelerator.

    How many vaccines are included in the plan?

    As of now, nine CEPI-supported candidate vaccines are included under the initiative. Further, nine other candidates are under evaluation, and procurement conversations are also underway with additional vaccine producers who are not receiving research and development (R&D) funding through COVAX at the moment. According to the WHO, COVAX has the world's "largest and most diverse COVID-19 vaccine portfolio."

    What is the COVAX plan?

    COVAX aims to accelerate the development of vaccines against COVID-19 by pooling funds from wealthier nations and guarantee fair and equitable access for every country in the world. The initiative has set a goal of delivering two billion doses of safe and effective vaccines that have passed regulatory approval and/or WHO prequalification by the end of 2021.

    'Unprecedented challenge can only be met with unprecedented cooperation'

    WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement, "COVID-19 is an unprecedented global health challenge that can only be met with unprecedented cooperation between governments, researchers, manufacturers, and multilateral partners." Earlier, Dr. Ghebreyesus had said that those at highest risk include healthcare professionals who are "critical to saving lives and stabilizing the overall health system."

    How many countries are involved?

    The initiative involves partnerships with developed and developing country vaccine manufacturers. The WHO said 172 countries are currently engaged in discussions to potentially participate in COVAX. 80 potentially self-financing countries have submitted non-binding expressions of interest to the COVAX facility, but only 43 have been named publicly including the United Kingdom, Singapore, Canada, New Zealand, Brazil, United Arab Emirates, etc.

    Who will benefit from this plan?

    Earlier in July, the Gavi board had agreed on 92 economies, including low income and lower-middle income countries, which will be supported by the COVAX Advance Market Commitment (AMC). India is among those eligible for support as a lower-middle income nation.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    World Health Organization
    Vaccine
    Tedros Adhanom Ghebreyesus
    COVID-19
    COVAX

    World Health Organization

    Hope world eradicates COVID-19 faster than Spanish Flu: WHO chief South Africa
    Lav Agarwal, government's face during press meets, tests coronavirus positive NITI Aayog
    Surgical, N95, or cloth: Which mask should you be wearing? United States of America
    Russia's COVID-19 vaccine candidate to be registered this week Russia News

    Vaccine

    China clears COVID-19 vaccines for emergency use: Details here Coronavirus
    Russia looking to partner with India for COVID-19 vaccine production Russia News
    India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials COVID-19
    Vipul Shah to make a web series on vaccine trials India

    Tedros Adhanom Ghebreyesus

    Young people not entirely safe from coronavirus, WHO reiterates World Health Organization
    WHO finally admits China didn't report about coronavirus outbreak World Health Organization
    Coronavirus, that killed over 500,000, isn't even nearing end: WHO South Korea
    Globally, the situation is worsening: WHO about coronavirus India

    COVID-19

    This robot can swab your nose for COVID-19 testing Technology
    Coronavirus: Last week was India's worst, cases and deaths surged Karnataka
    Legendary sprinter Usain Bolt tests positive for coronavirus Chris Gayle
    NewsBytes Briefing: Epic's Unreal Engine gets legal protection, and more Apple

    COVAX

    US won't participate in WHO-led global coronavirus vaccine effort World Health Organization
    India to get 10cr COVID-19 vaccine doses by December: SII India
    Coronavirus: WHO eyeing half-billion vaccine doses by 2021's first quarter Coronavirus
    India may have to spend $1.8 billion on coronavirus vaccine India
    Next News Article

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023